Yavuz B G, Aydinlar E I, Dikmen P Y. Association between somatic amplification, anxiety, depression, stress and migraine [J]. {H}JOURNAL OF HEADACHE AND PAIN, 2013(1):53.
|
Sharma K, Remanan R, Singh S. Quality of life and psychiatric co morbidity in Indian migraine patients:A headache clinic sample [J]. {H}NEUROLOGY INDIA, 2013(4):355.
|
Sheftell F D, Atlas S J. Migraine and psychiatric comorbidity:from theory and hypotheses to clinical application [J]. {H}HEADACHE, 2002(3):934.
|
Radat F, Mekies C, Géraud G. Anxiety, stress and coping behaviours in primary care migraine patients:reaults of the SMILE study [J]. {H}CEPHALALGIA, 2008.1115.
|
许勇, 丁红丽. 氟桂利嗪的临床应用 [J]. 临床合理用药, 2011, (9B):16.
|
Bourgeois J A, Hategan A. Flunarizine-and topiramate-associated depression responsive to mirtazapine [J]. {H}PSYCHOSOMATICS, 2013(5):503.
|
Pelzer N, Stam A H, Haan J. Familial and sporadic hemiplegic migraine:diagnosis and treatment [J]. {H}Current Treatment Options in Neurology, 2013(1):13.
|
Kim H, Byun S H, Kim J S. Comparison of flunarizine and topiramatc for the prophylaxis of pediatric migraines [J]. {H}European Journal of Neurology, 2013(1):45.
|
Russell J M, Weisberg R, Fava M. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms [J]. {H}DEPRESSION AND ANXIETY, 2008(7):E1.
|
喻东山. 度洛西汀的精神科应用 [J]. {H}临床荟萃, 2010, (22):2020.
|
Spence J D. Migraine, shear stress, and platelet serotonin [J]. {H}HEADACHE, 2013(3):552.
|